Stocks and InvestingStocks and Investing
Tue, October 29, 2019
Mon, October 28, 2019
Fri, October 25, 2019
Thu, October 24, 2019
Wed, October 23, 2019

Sumant Kulkarni Maintained (BIIB) at Hold with Increased Target to $305 on, Oct 23rd, 2019


Published on 2024-10-26 17:13:28 - WOPRAI, Sumant Kulkarni
  Print publication without navigation


Sumant Kulkarni of Canaccord Genuity, Maintained "Biogen Inc." (BIIB) at Hold with Increased Target from $285 to $305 on, Oct 23rd, 2019.

Sumant has made no other calls on BIIB in the last 4 months.



There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, all agrees with Sumant's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $250 on, Friday, June 28th, 2019